糖尿病薬の世界市場2020-2026:スルホニルウレア、ビグアナイド、メグリチニド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤

QYResearchが発行した調査報告書(QYR20AP00785)
◆英語タイトル:Global Diabetes Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00785
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:138
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥558,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥837,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、糖尿病薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、糖尿病薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(スルホニルウレア、ビグアナイド、メグリチニド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤)、用途別市場規模(診断/診療所、ICU、在宅医療)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・糖尿病薬の種類別市場2015-2026:スルホニルウレア、ビグアナイド、メグリチニド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤
・糖尿病薬の用途別市場2015-2026:診断/診療所、ICU、在宅医療
・糖尿病薬の北米市場分析
・糖尿病薬のアジア市場分析
・糖尿病薬の中南米市場分析
・糖尿病薬の中東・アフリカ市場分析
・関連企業情報:Sanofi、Novo Nordisk、MSD、Astrazeneca、Takeda、Novartis、North China Pharmaceutical Group Corporation、Huadong Medicine、Dongbao Pharmaceutical、Hisun Pharmacy、KELUN、Ginwa、Tianan Pharmaceutical、Jumpcan Pharmacy、Guangzhou Baiyun Mountain、SHIJIAZHUANG YILING PHARMACEUTICAL、Wanbang Biopharmaceuticals、Gan & Lee、Taloph
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that’s made by an organ called the pancreas. When the body doesn’t make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems – including blindness, kidney damage, heart disease and stroke. That’s why it’s important to take medicine that helps lower blood sugar levels. Diabetes can be managed so you can live a normal, healthy life.All diabetes drugs work to lower the levels of sugar in the blood. There are two basic types of diabetes drugs: pills by mouth and shots injected into the skin. More than one drug is often needed to manage diabetes. Some people try different pills, take more than one pill, or take a pill along with shots.
As World overall economic downward trend in the past few years, and international economic situation is complicated, in the next few years there will be many uncertainties, coupled with diabetes drug industry in short supply on the market in the past few years, more companies will enter into the diabetes drug industry, the current demand for diabetes drug product is relatively high; comparing to the ordinary diabetes drug products selling on the market. Diabetes drug’s price remains in the same level as compared with the past years. The signal of market price change indicates the trend in the diabetes drug industry, the market still have large potential.
In 2019, the global Diabetes Drugs market size was US$ 63620 million and is forecast to US$ 92310 million in 2026, growing at a CAGR of 5.4% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Diabetes Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Diabetes Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Diabetes Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Diabetes Drugs market. Readers of the report can become informed about current and future trends of the global Diabetes Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Diabetes Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Diabetes Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Diabetes Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Diabetes Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Diabetes Drugs market is segmented into
Sulphonylureas
Biguanides
Meglitinides
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
SGLT-2 Inhibitors

Market Segment by Application, the Diabetes Drugs market is segmented into
Diagnostic/Clinics
ICUs
Home Healthcare

This report includes the following manufacturers; we can also add the other companies as you want.
Sanofi
Novo Nordisk
MSD
Astrazeneca
Takeda
Novartis
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Jumpcan Pharmacy
Guangzhou Baiyun Mountain
SHIJIAZHUANG YILING PHARMACEUTICAL
Wanbang Biopharmaceuticals
Gan & Lee
Taloph

The study objectives are:
To analyze and research the global Diabetes Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Diabetes Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Diabetes Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Diabetes Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Diabetes Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Sulphonylureas
1.3.3 Biguanides
1.3.4 Meglitinides
1.3.5 Thiazolidinediones
1.3.6 Alpha-glucosidase Inhibitors
1.3.7 DPP-4 Inhibitors
1.3.8 SGLT-2 Inhibitors
1.4 Market Segment by Application
1.4.1 Global Diabetes Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Diagnostic/Clinics
1.4.3 ICUs
1.4.4 Home Healthcare
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Diabetes Drugs Revenue (2015-2026)
2.1.1 Global Diabetes Drugs Revenue (2015-2026)
2.1.2 Global Diabetes Drugs Sales (2015-2026)
2.2 Diabetes Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Diabetes Drugs Sales by Regions (2015-2020)
2.2.2 Global Diabetes Drugs Revenue by Regions (2015-2020)
2.3 Global Top Diabetes Drugs Regions (Countries) Ranking by Market Size
2.4 Diabetes Drugs Industry Trends
2.4.1 Diabetes Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Diabetes Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Diabetes Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Diabetes Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Diabetes Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Diabetes Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Diabetes Drugs Sales in 2019
3.2 Global Top Manufacturers Diabetes Drugs by Revenue
3.2.1 Global Diabetes Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Diabetes Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Diabetes Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drugs as of 2019)
3.4 Global Diabetes Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Diabetes Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Diabetes Drugs Market
3.7 Key Manufacturers Diabetes Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Diabetes Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Diabetes Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Diabetes Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Diabetes Drugs Price by Type (2015-2020)
4.1 Global Diabetes Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Diabetes Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Diabetes Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Diabetes Drugs Price Forecast by Type (2021-2026)

5 Global Diabetes Drugs Market Size by Application
5.1 Global Diabetes Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Diabetes Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Diabetes Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Diabetes Drugs Price by Application (2015-2020)
5.2 Global Diabetes Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Diabetes Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Diabetes Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Diabetes Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Diabetes Drugs Breakdown Data by Company
6.2 North America Diabetes Drugs Breakdown Data by Type
6.3 North America Diabetes Drugs Breakdown Data by Application
6.4 North America Diabetes Drugs Breakdown Data by Countries
6.4.1 North America Diabetes Drugs Sales by Countries
6.4.2 North America Diabetes Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Diabetes Drugs Breakdown Data by Company
7.2 Europe Diabetes Drugs Breakdown Data by Type
7.3 Europe Diabetes Drugs Breakdown Data by Application
7.4 Europe Diabetes Drugs Breakdown Data by Countries
7.4.1 Europe Diabetes Drugs Sales by Countries
7.4.2 Europe Diabetes Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Diabetes Drugs Breakdown Data by Company
8.2 Asia Pacific Diabetes Drugs Breakdown Data by Type
8.3 Asia Pacific Diabetes Drugs Breakdown Data by Application
8.4 Asia Pacific Diabetes Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Diabetes Drugs Sales by Regions
8.4.2 Asia Pacific Diabetes Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Diabetes Drugs Breakdown Data by Company
9.2 Latin America Diabetes Drugs Breakdown Data by Type
9.3 Latin America Diabetes Drugs Breakdown Data by Application
9.4 Latin America Diabetes Drugs Breakdown Data by Countries
9.4.1 Latin America Diabetes Drugs Sales by Countries
9.4.2 Latin America Diabetes Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Diabetes Drugs Breakdown Data by Type
10.2 Middle East and Africa Diabetes Drugs Breakdown Data by Application
10.3 Middle East and Africa Diabetes Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Diabetes Drugs Sales by Countries
10.3.2 Middle East and Africa Diabetes Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi Diabetes Drugs Products and Services
11.1.5 Sanofi SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Novo Nordisk Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Novo Nordisk Diabetes Drugs Products and Services
11.2.5 Novo Nordisk SWOT Analysis
11.2.6 Novo Nordisk Recent Developments
11.3 MSD
11.3.1 MSD Corporation Information
11.3.2 MSD Business Overview and Total Revenue (2019 VS 2018)
11.3.3 MSD Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 MSD Diabetes Drugs Products and Services
11.3.5 MSD SWOT Analysis
11.3.6 MSD Recent Developments
11.4 Astrazeneca
11.4.1 Astrazeneca Corporation Information
11.4.2 Astrazeneca Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Astrazeneca Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Astrazeneca Diabetes Drugs Products and Services
11.4.5 Astrazeneca SWOT Analysis
11.4.6 Astrazeneca Recent Developments
11.5 Takeda
11.5.1 Takeda Corporation Information
11.5.2 Takeda Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Takeda Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Takeda Diabetes Drugs Products and Services
11.5.5 Takeda SWOT Analysis
11.5.6 Takeda Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Novartis Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Novartis Diabetes Drugs Products and Services
11.6.5 Novartis SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 North China Pharmaceutical Group Corporation
11.7.1 North China Pharmaceutical Group Corporation Corporation Information
11.7.2 North China Pharmaceutical Group Corporation Business Overview and Total Revenue (2019 VS 2018)
11.7.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 North China Pharmaceutical Group Corporation Diabetes Drugs Products and Services
11.7.5 North China Pharmaceutical Group Corporation SWOT Analysis
11.7.6 North China Pharmaceutical Group Corporation Recent Developments
11.8 Huadong Medicine
11.8.1 Huadong Medicine Corporation Information
11.8.2 Huadong Medicine Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Huadong Medicine Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Huadong Medicine Diabetes Drugs Products and Services
11.8.5 Huadong Medicine SWOT Analysis
11.8.6 Huadong Medicine Recent Developments
11.9 Dongbao Pharmaceutical
11.9.1 Dongbao Pharmaceutical Corporation Information
11.9.2 Dongbao Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Dongbao Pharmaceutical Diabetes Drugs Products and Services
11.9.5 Dongbao Pharmaceutical SWOT Analysis
11.9.6 Dongbao Pharmaceutical Recent Developments
11.10 Hisun Pharmacy
11.10.1 Hisun Pharmacy Corporation Information
11.10.2 Hisun Pharmacy Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Hisun Pharmacy Diabetes Drugs Products and Services
11.10.5 Hisun Pharmacy SWOT Analysis
11.10.6 Hisun Pharmacy Recent Developments
11.11 KELUN
11.11.1 KELUN Corporation Information
11.11.2 KELUN Business Overview and Total Revenue (2019 VS 2018)
11.11.3 KELUN Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 KELUN Diabetes Drugs Products and Services
11.11.5 KELUN SWOT Analysis
11.11.6 KELUN Recent Developments
11.12 Ginwa
11.12.1 Ginwa Corporation Information
11.12.2 Ginwa Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Ginwa Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Ginwa Diabetes Drugs Products and Services
11.12.5 Ginwa SWOT Analysis
11.12.6 Ginwa Recent Developments
11.13 Tianan Pharmaceutical
11.13.1 Tianan Pharmaceutical Corporation Information
11.13.2 Tianan Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Tianan Pharmaceutical Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Tianan Pharmaceutical Diabetes Drugs Products and Services
11.13.5 Tianan Pharmaceutical SWOT Analysis
11.13.6 Tianan Pharmaceutical Recent Developments
11.14 Jumpcan Pharmacy
11.14.1 Jumpcan Pharmacy Corporation Information
11.14.2 Jumpcan Pharmacy Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Jumpcan Pharmacy Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Jumpcan Pharmacy Diabetes Drugs Products and Services
11.14.5 Jumpcan Pharmacy SWOT Analysis
11.14.6 Jumpcan Pharmacy Recent Developments
11.15 Guangzhou Baiyun Mountain
11.15.1 Guangzhou Baiyun Mountain Corporation Information
11.15.2 Guangzhou Baiyun Mountain Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Guangzhou Baiyun Mountain Diabetes Drugs Products and Services
11.15.5 Guangzhou Baiyun Mountain SWOT Analysis
11.15.6 Guangzhou Baiyun Mountain Recent Developments
11.16 SHIJIAZHUANG YILING PHARMACEUTICAL
11.16.1 SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
11.16.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview and Total Revenue (2019 VS 2018)
11.16.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Products and Services
11.16.5 SHIJIAZHUANG YILING PHARMACEUTICAL SWOT Analysis
11.16.6 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Developments
11.17 Wanbang Biopharmaceuticals
11.17.1 Wanbang Biopharmaceuticals Corporation Information
11.17.2 Wanbang Biopharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.17.3 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 Wanbang Biopharmaceuticals Diabetes Drugs Products and Services
11.17.5 Wanbang Biopharmaceuticals SWOT Analysis
11.17.6 Wanbang Biopharmaceuticals Recent Developments
11.18 Gan & Lee
11.18.1 Gan & Lee Corporation Information
11.18.2 Gan & Lee Business Overview and Total Revenue (2019 VS 2018)
11.18.3 Gan & Lee Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.18.4 Gan & Lee Diabetes Drugs Products and Services
11.18.5 Gan & Lee SWOT Analysis
11.18.6 Gan & Lee Recent Developments
11.19 Taloph
11.19.1 Taloph Corporation Information
11.19.2 Taloph Business Overview and Total Revenue (2019 VS 2018)
11.19.3 Taloph Diabetes Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.19.4 Taloph Diabetes Drugs Products and Services
11.19.5 Taloph SWOT Analysis
11.19.6 Taloph Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Diabetes Drugs Sales Channels
12.2.2 Diabetes Drugs Distributors
12.3 Diabetes Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Diabetes Drugs Sales Forecast (2021-2026)
13.1.1 Global Diabetes Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Diabetes Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Diabetes Drugs Sales Forecast (2021-2026)
13.2.2 North America Diabetes Drugs Revenue Forecast (2021-2026)
13.2.3 North America Diabetes Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Diabetes Drugs Sales Forecast (2021-2026)
13.3.2 Europe Diabetes Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Diabetes Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Diabetes Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Diabetes Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Diabetes Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Diabetes Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Diabetes Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Diabetes Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Diabetes Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Diabetes Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Diabetes Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Diabetes Drugs Key Market Segments
Table 2. Ranking of Global Top Diabetes Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Diabetes Drugs Market Size Growth Rate by Type 2021-2026 (K MT) & (Million US$)
Table 4. Major Manufacturers of Sulphonylureas
Table 5. Major Manufacturers of Biguanides
Table 6. Major Manufacturers of Meglitinides
Table 7. Major Manufacturers of Thiazolidinediones
Table 8. Major Manufacturers of Alpha-glucosidase Inhibitors
Table 9. Major Manufacturers of DPP-4 Inhibitors
Table 10. Major Manufacturers of SGLT-2 Inhibitors
Table 11. Global Diabetes Drugs Market Share by Application 2019-2025 (K MT)
Table 12. Global Diabetes Drugs Market Size by Regions 2015-2020 (K MT) & (Million US$)
Table 13. Global Diabetes Drugs Sales by Regions 2015-2020 (K MT)
Table 14. Global Diabetes Drugs Sales Market Share by Regions 2015-2020
Table 15. Global Diabetes Drugs Revenue by Regions 2015-2020 (Million US$)
Table 16. Global Diabetes Drugs Revenue Market Share by Regions 2015-2020
Table 17. Top Diabetes Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 18. Market Top Trends
Table 19. Diabetes Drugs Key Drivers: Impact Analysis (2021-2026)
Table 20. Diabetes Drugs Key Challenges
Table 21. Main Points Interviewed from Key Diabetes Drugs Players: Views for Future
Table 22. Global Diabetes Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 23. Global Diabetes Drugs Sales Share by Manufacturers (2015-2020)
Table 24. Diabetes Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Diabetes Drugs Revenue Share by Manufacturers (2015-2020)
Table 26. Global Diabetes Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drugs as of 2019)
Table 28. Key Manufacturers Diabetes Drugs Average Selling Price (ASP) (2015-2020) (USD/MT)
Table 29. Key Manufacturers Diabetes Drugs Plants/Factories Distribution
Table 30. Key Manufacturers Diabetes Drugs Area Served
Table 31. Date of Key Manufacturers Enter into Diabetes Drugs Market
Table 32. Key Manufacturers Diabetes Drugs Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Sulphonylureas Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 35. Global Biguanides Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 36. Global Meglitinides Sales ana Revenue (2015-2020) (K MT) & (Million US$)
Table 37. Global Thiazolidinediones Sales ana Revenue (2015-2020) (K MT) & (Million US$)
Table 38. Global Alpha-glucosidase Inhibitors Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 39. Global DPP-4 Inhibitors Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 40. Global SGLT-2 Inhibitors Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 41. Global Diabetes Drugs Sales (K MT) by Type (2015-2020)
Table 42. Global Diabetes Drugs Sales Share by Type (2015-2020)
Table 43. Global Diabetes Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Global Diabetes Drugs Price (K MT) by Type (2015-2020)
Table 45. Global Diabetes Drugs Sales (K MT) by Type (2021-2026)
Table 46. Global Diabetes Drugs Sales Share by Type (2021-2026)
Table 47. Global Diabetes Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Global Diabetes Drugs Revenue Share by Type (2021-2026)
Table 49. Global Diabetes Drugs Price (K MT) by Type (2021-2026)
Table 50. Global Diabetes Drugs Sales (K MT) by Application (2015-2020)
Table 51. Global Diabetes Drugs Sales Share by Application (2015-2020)
Table 52. Global Diabetes Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Global Diabetes Drugs Price by Application 2015-2020 (USD/MT)
Table 54. Global Diabetes Drugs Sales by Application (2015-2020) (K MT)
Table 55. Global Diabetes Drugs Sales Share by Application (2015-2020)
Table 56. Global Diabetes Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Global Diabetes Drugs Revenue Share by Application (2021-2026)
Table 58. Global Diabetes Drugs Price (K MT) by Application (2021-2026)
Table 59. North America Diabetes Drugs Sales by Company (2015-2020) (K MT)
Table 60. North America Diabetes Drugs Sales Market Share by Company (2015-2020)
Table 61. North America Diabetes Drugs Sales by Type (2015-2020) (K MT)
Table 62. North America Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 63. North America Diabetes Drugs Sales by Application (2015-2020) (K MT)
Table 64. North America Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 65. North America Diabetes Drugs Sales by Countries (2015-2020) (K MT)
Table 66. North America Diabetes Drugs Sales Market Share by Countries (2015-2020)
Table 67. North America Diabetes Drugs Revenue by Countries (2015-2020) (Million US$)
Table 68. North America Diabetes Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Europe Diabetes Drugs Sales by Company (2015-2020) (K MT)
Table 70. Europe Diabetes Drugs Sales Market Share by Company (2015-2020)
Table 71. Europe Diabetes Drugs Sales by Type (2015-2020) (K MT)
Table 72. Europe Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 73. Europe Diabetes Drugs Sales by Application (2015-2020) (K MT)
Table 74. Europe Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 75. Europe Diabetes Drugs Sales by Countries (2015-2020) (K MT)
Table 76. Europe Diabetes Drugs Sales Market Share by Countries (2015-2020)
Table 77. Europe Diabetes Drugs Revenue by Countries (2015-2020) (Million US$)
Table 78. Europe Diabetes Drugs Revenue Market Share by Countries (2015-2020)
Table 79. Asia Pacific Diabetes Drugs Sales by Regions (2015-2020) (K MT)
Table 80. Asia Pacific Diabetes Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Diabetes Drugs Sales by Type (2015-2020) (K MT)
Table 82. Asia Pacific Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 83. Asia Pacific Diabetes Drugs Sales by Application (2015-2020) (K MT)
Table 84. Asia Pacific Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 85. Asia Pacific Diabetes Drugs Sales by Countries (2015-2020) (K MT)
Table 86. Asia Pacific Diabetes Drugs Sales Market Share by Regions (2015-2020)
Table 87. Asia Pacific Diabetes Drugs Revenue by Regions (2015-2020) (Million US$)
Table 88. Asia Pacific Diabetes Drugs Revenue Market Share by Regions (2015-2020)
Table 89. Latin America Diabetes Drugs Sales by Company (2015-2020) (K MT)
Table 90. Latin America Diabetes Drugs Sales Market Share by Company (2015-2020)
Table 91. Latin America Diabetes Drugs Sales by Type (2015-2020) (K MT)
Table 92. Latin America Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 93. Latin America Diabetes Drugs Sales by Application (2015-2020) (K MT)
Table 94. Latin America Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 95. Latin America Diabetes Drugs Sales by Countries (2015-2020) (K MT)
Table 96. Latin America Diabetes Drugs Sales Market Share by Countries (2015-2020)
Table 97. Latin America Diabetes Drugs Revenue by Countries (2015-2020) (Million US$)
Table 98. Latin America Diabetes Drugs Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Diabetes Drugs Sales by Type (2015-2020) (K MT)
Table 100. Middle East and Africa Diabetes Drugs Sales Market Share by Type (2015-2020)
Table 101. Middle East and Africa Diabetes Drugs Sales by Application (2015-2020) (K MT)
Table 102. Middle East and Africa Diabetes Drugs Sales Market Share by Application (2015-2020)
Table 103. Middle East and Africa Diabetes Drugs Sales by Countries (2015-2020) (K MT)
Table 104. Middle East and Africa Diabetes Drugs Sales Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Diabetes Drugs Revenue by Countries (2015-2020) (Million US$)
Table 106. Middle East and Africa Diabetes Drugs Revenue Market Share by Countries (2015-2020)
Table 107. Sanofi Company Details
Table 108. Sanofi Description and Business Overview
Table 109. Sanofi Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Sanofi Diabetes Drugs Sales Growth Rate (2015-2020)
Table 111. Sanofi Diabetes Drugs Sales Market Share in Global Market
Table 112. Sanofi Recent Development
Table 113. Novo Nordisk Company Details
Table 114. Novo Nordisk Description and Business Overview
Table 115. Novo Nordisk Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Novo Nordisk Diabetes Drugs Sales Growth Rate (2015-2020)
Table 117. Novo Nordisk Diabetes Drugs Sales Market Share in Global Market
Table 118. Novo Nordisk Recent Development
Table 119. MSD Company Details
Table 120. MSD Description and Business Overview
Table 121. MSD Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. MSD Diabetes Drugs Sales Growth Rate (2015-2020)
Table 123. MSD Diabetes Drugs Sales Market Share in Global Market
Table 124. MSD Recent Development
Table 125. Astrazeneca Company Details
Table 126. Astrazeneca Description and Business Overview
Table 127. Astrazeneca Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Astrazeneca Diabetes Drugs Sales Growth Rate (2015-2020)
Table 129. Astrazeneca Diabetes Drugs Sales Market Share in Global Market
Table 130. Astrazeneca Recent Development
Table 131. Takeda Company Details
Table 132. Takeda Description and Business Overview
Table 133. Takeda Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Takeda Diabetes Drugs Sales Growth Rate (2015-2020)
Table 135. Takeda Diabetes Drugs Sales Market Share in Global Market
Table 136. Takeda Recent Development
Table 137. Novartis Company Details
Table 138. Novartis Description and Business Overview
Table 139. Novartis Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Novartis Diabetes Drugs Sales Growth Rate (2015-2020)
Table 141. Novartis Diabetes Drugs Sales Market Share in Global Market
Table 142. Novartis Recent Development
Table 143. North China Pharmaceutical Group Corporation Company Details
Table 144. North China Pharmaceutical Group Corporation Description and Business Overview
Table 145. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. North China Pharmaceutical Group Corporation Diabetes Drugs Sales Growth Rate (2015-2020)
Table 147. North China Pharmaceutical Group Corporation Diabetes Drugs Sales Market Share in Global Market
Table 148. North China Pharmaceutical Group Corporation Recent Development
Table 149. Huadong Medicine Company Details
Table 150. Huadong Medicine Description and Business Overview
Table 151. Huadong Medicine Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Huadong Medicine Diabetes Drugs Sales Growth Rate (2015-2020)
Table 153. Huadong Medicine Diabetes Drugs Sales Market Share in Global Market
Table 154. Huadong Medicine Recent Development
Table 155. Dongbao Pharmaceutical Company Details
Table 156. Dongbao Pharmaceutical Description and Business Overview
Table 157. Dongbao Pharmaceutical Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Dongbao Pharmaceutical Diabetes Drugs Sales Growth Rate (2015-2020)
Table 159. Dongbao Pharmaceutical Diabetes Drugs Sales Market Share in Global Market
Table 160. Dongbao Pharmaceutical Recent Development
Table 161. Hisun Pharmacy Company Details
Table 162. Hisun Pharmacy Description and Business Overview
Table 163. Hisun Pharmacy Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 164. Hisun Pharmacy Diabetes Drugs Sales Growth Rate (2015-2020)
Table 165. Hisun Pharmacy Diabetes Drugs Sales Market Share in Global Market
Table 166. Hisun Pharmacy Recent Development
Table 167. KELUN Company Details
Table 168. KELUN Description and Business Overview
Table 169. KELUN Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 170. KELUN Diabetes Drugs Sales Growth Rate (2015-2020)
Table 171. KELUN Diabetes Drugs Sales Market Share in Global Market
Table 172. KELUN Recent Development
Table 173. Ginwa Company Details
Table 174. Ginwa Description and Business Overview
Table 175. Ginwa Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 176. Ginwa Diabetes Drugs Sales Growth Rate (2015-2020)
Table 177. Ginwa Diabetes Drugs Sales Market Share in Global Market
Table 178. Ginwa Recent Development
Table 179. Tianan Pharmaceutical Company Details
Table 180. Tianan Pharmaceutical Description and Business Overview
Table 181. Tianan Pharmaceutical Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 182. Tianan Pharmaceutical Diabetes Drugs Sales Growth Rate (2015-2020)
Table 183. Tianan Pharmaceutical Diabetes Drugs Sales Market Share in Global Market
Table 184. Tianan Pharmaceutical Recent Development
Table 185. Jumpcan Pharmacy Company Details
Table 186. Jumpcan Pharmacy Description and Business Overview
Table 187. Jumpcan Pharmacy Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Jumpcan Pharmacy Diabetes Drugs Sales Growth Rate (2015-2020)
Table 189. Jumpcan Pharmacy Diabetes Drugs Sales Market Share in Global Market
Table 190. Jumpcan Pharmacy Recent Development
Table 191. Guangzhou Baiyun Mountain Company Details
Table 192. Guangzhou Baiyun Mountain Description and Business Overview
Table 193. Guangzhou Baiyun Mountain Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 194. Guangzhou Baiyun Mountain Diabetes Drugs Sales Growth Rate (2015-2020)
Table 195. Guangzhou Baiyun Mountain Diabetes Drugs Sales Market Share in Global Market
Table 196. Guangzhou Baiyun Mountain Recent Development
Table 197. SHIJIAZHUANG YILING PHARMACEUTICAL Company Details
Table 198. SHIJIAZHUANG YILING PHARMACEUTICAL Description and Business Overview
Table 199. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 200. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales Growth Rate (2015-2020)
Table 201. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales Market Share in Global Market
Table 202. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
Table 203. Wanbang Biopharmaceuticals Company Details
Table 204. Wanbang Biopharmaceuticals Description and Business Overview
Table 205. Wanbang Biopharmaceuticals Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 206. Wanbang Biopharmaceuticals Diabetes Drugs Sales Growth Rate (2015-2020)
Table 207. Wanbang Biopharmaceuticals Diabetes Drugs Sales Market Share in Global Market
Table 208. Wanbang Biopharmaceuticals Recent Development
Table 209. Gan & Lee Company Details
Table 210. Gan & Lee Description and Business Overview
Table 211. Gan & Lee Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 212. Gan & Lee Diabetes Drugs Sales Growth Rate (2015-2020)
Table 213. Gan & Lee Diabetes Drugs Sales Market Share in Global Market
Table 214. Gan & Lee Recent Development
Table 215. Taloph Company Details
Table 216. Taloph Description and Business Overview
Table 217. Taloph Diabetes Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 218. Taloph Diabetes Drugs Sales Growth Rate (2015-2020)
Table 219. Taloph Diabetes Drugs Sales Market Share in Global Market
Table 220. Taloph Recent Development
Table 221. Diabetes Drugs Distributors List
Table 222. Diabetes Drugs Customers List
Table 223. Global Diabetes Drugs Sales Forecast 2021-2026 (K MT) & (Million US$)
Table 224. Global Diabetes Drugs Sales Forecast by Type 2021-2026 (K MT)
Table 225. Global Diabetes Drugs Sales Forecast by Application 2021-2026 (K MT)
Table 226. Global Diabetes Drugs Sales Forecast by Regions 2021-2026 (K MT)
Table 227. Global Diabetes Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 228. North America Diabetes Drugs Sales Forecast by Countries 2021-2026 (K MT)
Table 229. North America Diabetes Drugs Revenue Forecast by Countries 2021-2026
Table 230. Europe Diabetes Drugs Sales Forecast by Countries 2021-2026 (K MT)
Table 231. Europe Diabetes Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 232. Asia Pacific Diabetes Drugs Sales Forecast by Regions 2021-2026 (K MT)
Table 233. Asia Pacific Diabetes Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 234. Latin America Diabetes Drugs Sales Forecast by Countries 2021-2026 (K MT)
Table 235. Latin America Diabetes Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 236. Middle East and Africa Diabetes Drugs Sales Forecast by Regions 2021-2026 (K MT)
Table 237. Middle East and Africa Diabetes Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Drugs Product Picture
Figure 2. Global Diabetes Drugs Sales Market Shar by Type 2015-2026
Figure 3. Sulphonylureas Figures
Figure 4. Biguanides Figures
Figure 5. Meglitinides Figures
Figure 6. Thiazolidinediones Figures
Figure 7. Alpha-glucosidase Inhibitors Figures
Figure 8. DPP-4 Inhibitors Figures
Figure 9. SGLT-2 Inhibitors Figures
Figure 10. Global Diabetes Drugs Sales Market Share by Application in 2019 & 2026
Figure 11. Diagnostic/Clinics Use Case
Figure 12. ICUs Use Case
Figure 13. Home Healthcare Use Case
Figure 14. Diabetes Drugs Report Years Considered
Figure 15. Global Diabetes Drugs Market Size 2015-2026 (Million US$)
Figure 16. Global Diabetes Drugs Sales 2015-2020 (K MT)
Figure 17. Global Diabetes Drugs Market Size Market Share by Regions 2015-2020
Figure 18. Global Diabetes Drugs Sales Market Share by Regions in 2019
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Diabetes Drugs Sales Share by Manufacturers in 2019
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Drugs Sales in 2019
Figure 22. Diabetes Drugs Value Share by Manufacturers in 2019
Figure 23. Diabetes Drugs Revenue Share by Manufacturers In 2019
Figure 24. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Diabetes Drugs Revenue Share by Type (2015-2020)
Figure 26. Global Diabetes Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 27. Global Diabetes Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Diabetes Drugs Revenue Share by Application (2015-2020)
Figure 29. Global Diabetes Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 30. North America Diabetes Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. U.S. Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 32. Canada Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 33. Europe Diabetes Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. Germany Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. France Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.K. Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Russia Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 39. Asia Pacific Diabetes Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 40. China Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. Japan Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 42. South Korea Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. India Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Australia Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Taiwan Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Indonesia Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Thailand Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. Malaysia Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. Philippines Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Vietnam Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Latin America Diabetes Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Mexico Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Brazil Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Argentina Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Middle East and Africa Diabetes Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 56. Turkey Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Saudi Arabia Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. U.A.E Diabetes Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. MSD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. North China Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Huadong Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Dongbao Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Hisun Pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. KELUN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Ginwa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Tianan Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Jumpcan Pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Guangzhou Baiyun Mountain Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. SHIJIAZHUANG YILING PHARMACEUTICAL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Wanbang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Gan & Lee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Taloph Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Diabetes Drugs Value Chain
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. North America Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 82. North America Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 83. Europe Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 84. Europe Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 85. Asia Pacific Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 86. Asia Pacific Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 87. Latin America Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 88. Latin America Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 89. Middle East and Africa Diabetes Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 90. Middle East and Africa Diabetes Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


【掲載企業】

Sanofi、Novo Nordisk、MSD、Astrazeneca、Takeda、Novartis、North China Pharmaceutical Group Corporation、Huadong Medicine、Dongbao Pharmaceutical、Hisun Pharmacy、KELUN、Ginwa、Tianan Pharmaceutical、Jumpcan Pharmacy、Guangzhou Baiyun Mountain、SHIJIAZHUANG YILING PHARMACEUTICAL、Wanbang Biopharmaceuticals、Gan & Lee、Taloph

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病薬の世界市場2020-2026:スルホニルウレア、ビグアナイド、メグリチニド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤(Global Diabetes Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。